Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q4 FY21 results · Jan–Mar 2021

Insecticides (India) reported revenue from operations of ₹255.60 crore (up 7.1% from Q4 FY20) and net profit of ₹21.78 crore for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY21Q4 FY20YoYQ3 FY21QoQ
Revenue from operations255.60238.67+7.1%299.17−14.6%
Other income2.13(0.92)Turned profit1.03+106.7%
Total income257.74237.75+8.4%300.21−14.1%
Profit before share of associates & JVs and tax23.79(14.66)Turned profit8.06+195.3%
Share of profit/(loss) of associates & JVs(0.17)0.200.15
Net profit for the period21.78(7.11)Turned profit6.15+254.3%
EPS, basic (₹)10.54(3.54)Turned profit2.97+254.9%
Net margin (%)8.5-3.02.1

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ4 FY21Q4 FY20YoYQ3 FY21QoQ
Revenue from operations255.60238.67+7.1%299.17−14.6%
Other income2.13(0.92)Turned profit1.03+106.7%
Total income257.74237.75+8.4%300.21−14.1%
Profit before tax23.79(14.66)Turned profit8.06+195.3%
Net profit for the period21.95(7.32)Turned profit6.00+266.0%
EPS, basic (₹)10.63(3.54)Turned profit2.90+266.6%
Net margin (%)8.6-3.12.0
Consolidated
Filed with BSE
18 Jun 2021, 17:22 IST
Board meeting
18 Jun 2021
Period
01 Jan 2021 to 31 Mar 2021
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
18 Jun 2021, 17:22 IST
Board meeting
18 Jun 2021
Period
01 Jan 2021 to 31 Mar 2021
Review status
Audited
Source
XBRL filing on BSE